Tofacitinib is currently under review as induction and/or maintenance therapy for adult patients with moderate-to-severe ulcerative colitis. How does it compare with other biologics?
Alimentary Pharmacology & Therapeutics
Original Article: Tofacitinib and Biological Therapies for Ulcerative Colitis